Back

The prognostic value of ST-2 in adults with congenital heart disease

26 August 2018 (15:26 - 15:35)
Organised by:
Congress Presentation Part of: Risk stratification in congenital heart disease Adult Congenital Heart Disease (ACHD) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Ms Laurie Willemijn Geenen

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Repeated measurements of cardiac biomarkers for risk prediction in pulmonary arterial hypertension associated with congenital heart disease: a 10-year observational cohort study
Ms A. van Dissel (Amsterdam, NL)
Abstract
Presentation thumbnail
Development and validation of a risk prediction model in patients with adult congenital heart disease
Ms V. Baggen (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Prognostic value of echocardiographic and blood biomarkers in patients with a systemic right ventricle
Doctor A. Van Den Bosch (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Predictors of mortality following hospitalisation in adults with congenital heart disease
Doctor A. Khokhar (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Risk stratification and clinical outcomes after pulmonary valve replacement
Doctor A. Egbe (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in congenital heart disease

The Event

Event poster

ESC Congress 2018

26 August 2018 15:26 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic markers in adults with congenital heart disease and incident heart failure: Insights from a nationwide study
1 September 2025
thumbnail
Congress Presentation
Head-to-head comparison of NT-proBNP and soluble ST2 for long-term prognosis of patients with hypertrophic cardiomyopathy
27 August 2021
thumbnail
Congress Session
Congenitally corrected transposition of the great arteries (CCTGA): what are the treatment challenges?
26 August 2023
thumbnail
Congress Presentation
Impact of left atrial size and strain on new atrial arrhythmias during a 5-year follow-up in adults with congenital heart disease
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources